ATAI Life Valuation
| ATAI Stock | USD 1.33 0.03 2.21% |
Today, the firm appears to be overvalued. ATAI Life Sciences owns a latest Real Value of $1.16 per share. The recent price of the firm is $1.33. Our model approximates the value of ATAI Life Sciences from analyzing the firm fundamentals such as return on asset of -0.25, and Shares Owned By Insiders of 9.98 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ATAI Life's price fluctuation is extremely dangerous at this time. Calculation of the real value of ATAI Life Sciences is based on 3 months time horizon. Increasing ATAI Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ATAI Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ATAI Stock. However, ATAI Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.33 | Real 1.16 | Hype 1.33 |
The intrinsic value of ATAI Life's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence ATAI Life's stock price.
Estimating the potential upside or downside of ATAI Life Sciences helps investors to forecast how ATAI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ATAI Life more accurately as focusing exclusively on ATAI Life's fundamentals will not take into account other important factors: ATAI Life Total Value Analysis
ATAI Life Sciences is presently forecasted to have valuation of 166.1 M with market capitalization of 228.21 M, debt of 19.14 M, and cash on hands of 304.06 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ATAI Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
166.1 M | 228.21 M | 19.14 M | 304.06 M |
ATAI Life Investor Information
About 27.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.57. Some equities with similar Price to Book (P/B) outperform the market in the long run. ATAI Life Sciences recorded a loss per share of 0.8. The entity last dividend was issued on the 27th of August 2018. Based on the measurements of operating efficiency obtained from ATAI Life's historical financial statements, ATAI Life Sciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.ATAI Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ATAI Life has an asset utilization ratio of 0.11 percent. This signifies that the Company is making $0.00107 for each dollar of assets. An increasing asset utilization means that ATAI Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.ATAI Life Ownership Allocation
ATAI Life Sciences secures a total of 167.8 Million outstanding shares. ATAI Life Sciences owns 9.98 % of its outstanding shares held by insiders and 26.76 % owned by institutions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.ATAI Life Profitability Analysis
The company reported the previous year's revenue of 314 K. Net Loss for the year was (40.22 M) with profit before overhead, payroll, taxes, and interest of 233 K.About ATAI Life Valuation
An absolute valuation paradigm, as applied to ATAI Stock, attempts to find the value of ATAI Life Sciences based on its fundamental and basic technical indicators. By analyzing ATAI Life's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ATAI Life's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ATAI Life. We calculate exposure to ATAI Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ATAI Life's related companies.Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
ATAI Life Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 158.8 M | |
| Quarterly Earnings Growth Y O Y | -0.968 |
Complementary Tools for ATAI Stock analysis
When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |